Edition:
Deutschland

Pain Therapeutics Inc (PTIE.OQ)

PTIE.OQ on NASDAQ Stock Exchange Capital Market

1.15USD
13 Nov 2018
Change (% chg)

-- (--)
Prev Close
$1.15
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
331,498
52-wk High
$12.80
52-wk Low
$0.81

PTIE.OQ

Chart for PTIE.OQ

About

Pain Therapeutics, Inc. is a biopharmaceutical company. The Company is focused on drug development efforts on disorders of the nervous system, such as chronic pain. The Company's lead drug candidate, REMOXY, is an abuse-deterrent, oral formulation of oxycodone (CII). The Company's other products is FENROCK. REMOXY is a... (more)

Buy/Sell

No Data Available
Sell Hold Buy

Overall

Beta: 2.17
Market Cap(Mil.): $28.03
Shares Outstanding(Mil.): 6.60
Dividend: --
Yield (%): --

UPDATE 2-FDA declines to approve Pain Therapeutics' opioid drug, shares plunge

* Shares fall 35 pct to record low (Adds analyst comment, updates share movement)

U.S. FDA declines to approve Pain Therapeutics' opioid drug

Aug 6 Pain Therapeutics' said on Monday that the U.S. Food and Drug Administration declined to approve the company's opioid drug for the management of severe pain as the benefits of the drug did not outweigh the risk.

Märkte

  • U.S.
  • Europa
  • Asien
  • Branchen

Branchenüberblick

Energie -0.43%
Rohstoffe -0.29%
Industrie +0.01%
Konjunktur abhängige Waren & Dienstleistungen +0.01%
Konjunktur unabhängige Waren & Dienstleistungen -0.16%
Finanzindustrie -0.16%
Pharma -0.07%
Technologie +0.23%
Telekommunikation +0.13%

Nachrichten aus der Wirtschaft